CVS Health Corporation (NYSE:CVS) is flat on Wednesday. The shares dropped by almost 15% yesterday after it was reported that Medicare was proposing rates that are well below expectations. • What’s driving CVS shares today?If the shares continue to trend lower, they may find support around $70. They may even rally off this level. This is why CVS is the Stock of the Day.Successful traders understand which price levels in a market are important. These are called support and resistance levels.If a stock is tre ...

BRAMPTON, Ontario, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Loblaw Companies Limited (TSX: L) announced today that it will release its 2025 fourth quarter and full year results on February 25, 2026, at approximately 6:30 a.m. (ET). The release will be followed by a conference call at 10:00 a.m. (ET), as well as an audio webcast. To access via audio webcast please go to the “Investor” section of loblaw.ca, and note that pre-registration will be available. Alternatively, please dial (647) 932-3411 or Toll-Free (800) ...

登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码：002727 股票简称：一心堂 公告编号：2026-010号 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日。 2、业绩预告情况：预计净利润为正值且属于同向上升50%以上情形 （1）以区间数进行业绩预告的 四、风险提示 本次业绩预告是公司财务部门初步核算的结果，具体财务数据将在公司2025年年度报告中详细披露。敬 请广大投资者审慎决策，注意投资风险。 特此公告。 一心堂药业集团股份有限公司 单位：万元 二、与会计师事务所沟通情况 本次业绩预告未经会计师事务所审计。公司已就本次业绩预告情况与年报审计会计师事务所进行沟通， 公司与会计师事务所对于本次业绩预告不存在分歧。 三、业绩变动原因说明 公司门店拓展方面，截至2025年12月31日，公司拥有直营连锁门店11,112家，全年净减少386家。2025 年，通过精细化管理和一系列措施，优化资源配置，确保费用支出与业务目标相匹配，从而提高公司运 营效率和盈利能力。 2025年 ...

扬子晚报网1月22日讯(记者姜婧仪通讯员赵君)为解决老人"买药难、用药难"问题，南京雨花台区市场监管局将"精准助老"药事服务延伸至 社区"最后一米"。通过在各街道(园区)筛选因病致贫的困难老年群体作为重点帮扶对象，并依托辖区药店建立"一对一"结对帮扶机制，由 执业药师定期上门提供个性化药学服务，将专业与温情送到老人心坎上，让夕阳更红、晚年更暖。 上门服务 目前，雨花台区"精准助老"药事服务已实现8个街道园区全覆盖，筑康、高济再康、益丰、海王星辰等企业积极响应，共设立8个服务站 点，构建起一张严密的"护老网"。从"坐堂问诊"转向"上门服务"，执业药师们不仅提供科普宣讲、建档随访等专业药事服务，更延伸至生 活温情关怀。截至2025年底，精准助老项目累计出动人员1035人次，上门服务481人次，开展药品安全讲座21次，惠及居民千余人，真正 打通了健康服务的"最后一公里"。 低保户周阿姨有多年的高血压糖尿病史，还有脑梗、胃癌病史，每日需服用8种药品，因用药结构复杂，周阿姨不仅常常记混、吃错，而 且容易发生合并用药不良反应。对此，结对的何药师为周阿姨量身定制了"个人用药档案"，把复杂的用药方案化繁为简，详细标注了每种 ...

Core Insights - The S&P 500 is experiencing unprecedented concentration, with the 10 largest companies accounting for about 40% of the index's weight, significantly above the long-term average of approximately 20% [1][2] Group 1: Market Concentration - Analysts express concern that high concentration may lead to lower S&P 500 returns over the next decade compared to a less concentrated market [2] - The top 10 stocks in the S&P 500 account for 35% of the index's earnings, making the current weight of 40% reasonable [6] Group 2: Investment Alternatives - The Invesco S&P 500 Revenue ETF tracks the S&P 500 but weights stocks based on trailing-12-month revenue, imposing a 5% weight cap on individual stocks [3][5] - The Invesco S&P 500 Equal Weight ETF measures performance by giving equal weight to all constituents, eliminating concentration risk entirely [8][9] Group 3: Performance and Fees - The Invesco S&P 500 Revenue ETF has returned 545% since its inception in 2008, while the S&P 500 has returned 630%, indicating potential for continued underperformance due to concentration risk [6][10] - The Invesco S&P 500 Revenue ETF has a relatively high expense ratio of 0.39%, while the Invesco S&P 500 Equal Weight ETF has a lower expense ratio of 0.2%, making it a more cost-effective option for investors seeking exposure without concentration risk [7][11]

Group 1: Mergers and Acquisitions Activity - Global mergers and acquisitions activity rebounded strongly in 2025, driven by easing monetary policy in the US, rising demand for AI capabilities, and improving macroeconomic stability [1] - US M&A volume approached $2.3 trillion in 2025, representing a 49% increase from the prior year, while global deal value rose more than 25% [3] Group 2: Key Transactions - Netflix agreed to acquire Warner Bros Discovery's studios and streaming business for $72 billion in equity value, following a competitive bidding process [4] - Anglo American and Teck Resources announced a merger of equals valued at approximately $53 billion, forming a copper-focused mining company [6] - Alphabet's Google announced an agreement to acquire cloud security firm Wiz for $32 billion, marking its largest acquisition to date [8] - Union Pacific and Norfolk Southern proposed an $85 billion merger to create the first transcontinental railroad network in the US [10] - Sycamore Partners completed its acquisition of Walgreens Boots Alliance in a transaction valued at up to $23.7 billion [12] - Sintana Energy agreed to acquire Challenger Energy Group in an all-share transaction valued at approximately C$83.6 million [14] - Lumine Group entered into an agreement to acquire Synchronoss Technologies in an all-cash transaction valued at $116.4 million [16] - Volato Group and M2i Global agreed to a business combination structured as a reverse merger [18] Group 3: Strategic Implications - The Netflix acquisition is expected to significantly expand its content production and distribution footprint [5] - The Anglo American and Teck merger is projected to yield annual pre-tax recurring synergies of about $800 million by the fourth year [7] - The Union Pacific and Norfolk Southern merger is expected to generate annual synergies of $2.75 billion [11] - The acquisition of Wiz is aimed at strengthening Google Cloud's cybersecurity offerings amid intensifying competition [9]

Core Insights - The U.S. Federal Reserve has cut key interest rates by 25 basis points for the third time in 2025, which may lead investors to consider dividend stocks for stable income and enhanced returns [1] Group 1: Dividend Stocks Overview - Top Wall Street analysts have identified attractive dividend-paying stocks, which can assist investors in making informed decisions [2] Group 2: Devon Energy - Devon Energy (DVN) returned $401 million to shareholders in Q3 2025 through share repurchases and dividends, with a fixed quarterly dividend of $0.24 per share, yielding 2.5% [3] - JP Morgan analyst Arun Jayaram upgraded DVN to buy from hold, lowering the price target to $44 from $49, citing compelling valuation and free cash flow gains from a $1 billion optimization plan [4][5] - Devon achieved approximately 60% of its $1 billion optimization goal within six months, and Jayaram expects stable well productivity in 2026 and 2027 [5][6] - Jayaram is optimistic about Devon's acreage position in key regions and its potential for lower-risk, high-return drilling opportunities [7] Group 3: EOG Resources - EOG Resources (EOG) paid $545 million in dividends and repurchased $440 million in shares in Q3 2025, with a quarterly dividend of $1.02 per share, yielding 3.7% [9] - Siebert Williams Shank analyst Gabriele Sorbara reaffirmed a buy rating on EOG with a price target of $150, highlighting its ability to navigate commodity cycles and strong free cash flow generation [11] - EOG is committed to returning at least 70% of its free cash flow to shareholders, with the potential to return 100% based on its balance sheet strength [12] - The company is leveraging advanced technology to identify multiple development targets in the Delaware Basin and is ahead of its synergy targets from the Encino acquisition [13] Group 4: CVS Health - CVS Health (CVS) is undergoing a turnaround, expecting a mid-teens adjusted EPS CAGR through 2028, with a quarterly dividend of $0.665 per share, yielding 3.4% [15] - Mizuho analyst Ann Hynes reiterated a buy rating on CVS, raising the price target to $95, citing structural improvements in retail earnings [16] - CVS' mid-teens adjusted EPS CAGR target does not include potential share buybacks, which may occur once leverage targets are met [17] - The company anticipates a decline in the medical loss ratio by about 50 basis points in 2026, driven by better pricing and strategic exits from certain business segments [18] - CVS expects flat adjusted operating income growth in its Pharmacy and Consumer Wellness segment, improved by market share gains and cost savings [19]

Core Viewpoint - CVS Health has become a leading performer in the healthcare sector under CEO David Joiner, with stock prices increasing by 2% following the announcement of optimistic long-term earnings targets [1]. Group 1: Company Transformation and Strategy - CVS Health is focused on transforming healthcare delivery in America, emphasizing consumer engagement and improved relationships with healthcare providers through technology [2][3]. - The company aims to enhance operational efficiency and productivity while addressing consumer frustrations regarding healthcare costs and navigation [5][4]. - CVS Health has set ambitious long-term growth targets, projecting a compound annual growth rate (CAGR) of 15% by 2028, with a commitment to delivering on promises made to stakeholders [6][7]. Group 2: Business Performance and Recovery - Over the past year, CVS Health has successfully stabilized its business, particularly in the retail sector, which has shifted from a decline of 5% to a growth trajectory [11]. - The company has reported consistent performance improvements, having beaten and raised guidance for four consecutive quarters [7][20]. - CVS Health is positioning its retail business as a gateway to other enterprise services, leveraging consumer trust to enhance overall healthcare delivery [12]. Group 3: Healthcare Cost Management - CVS Health is addressing the high costs associated with rare diseases, which represent 2% of the population but account for 50% of healthcare spending, by managing pharmacy benefits and introducing competition to lower costs [15][18]. - The average price for new branded medications is reported to be $350,000, highlighting the need for affordable solutions in the healthcare market [16]. Group 4: Role of Pharmacists - CVS Health is focusing on maximizing the role of its 30,000 pharmacists, aiming to utilize them as primary care providers to address access issues in healthcare [22][24]. - The company believes that elevating the role of pharmacists will enhance patient care and strengthen consumer relationships [24].

Core Insights - CVS Health is providing the measles-mumps-rubella (MMR) vaccine at over 200 locations in South Carolina to combat a measles outbreak [1][3] - The MMR vaccine is available for residents aged three and older, with specific vaccination protocols for children aged 4-6 [4] Group 1: Vaccination Availability - CVS Pharmacy and MinuteClinic locations are offering the MMR vaccine to unvaccinated residents in South Carolina [1] - Patients are encouraged to schedule vaccination appointments in advance through CVS.com or the CVS Health app to ensure availability [5] Group 2: Measles Information - Measles is highly contagious, with up to 90% infection rates among unprotected individuals in close proximity to an infected person [3] - Symptoms of measles can appear 7 to 14 days after exposure, including fever, cough, runny nose, and a red, blotchy rash [2][3] Group 3: Company Overview - As of September 30, 2025, CVS Health operates approximately 9,000 retail pharmacy locations and over 1,000 walk-in medical clinics [6] - The company serves around 87 million pharmacy benefits plan members and more than 37 million individuals through various health insurance products [6]

Core Viewpoint - The company has received high ESG scores from S&P Global and Refinitiv, indicating strong performance in sustainability practices and positioning it as a leader among private pharmaceutical retail enterprises in China [1][2]. Group 1: ESG Ratings - S&P Global has assigned an ESG score of 24, marking two consecutive years of growth, while Refinitiv's score has increased to 59, both ranking the company first among private listed pharmaceutical retailers in China [1]. - The S&P Global Corporate Sustainability Assessment (CSA) is recognized as one of the largest annual evaluations of corporate sustainability practices, providing critical data for investment decisions [1]. Group 2: Strategic Commitment to ESG - The company emphasizes the integration of ESG principles into its operations, establishing a three-tier governance structure with a dedicated Strategic and ESG Committee [2]. - The company has committed to disclosing its corporate social responsibility reports for ten consecutive years, with the 2023 and 2024 reports upgraded to ESG reports [2]. Group 3: Social Responsibility and Community Impact - The company operates over 15,000 stores across 18 provincial markets, creating nearly 60,000 job opportunities and actively engaging in social responsibility initiatives, including donations exceeding 100 million yuan [2]. - The company aims to foster a fair and transparent business environment while contributing to green and coordinated social development [2].